Immunoglobulin dynamics and infection risk with ofatumumab versus ocrelizumab in multiple sclerosis

Multiple Sclerosis and Related Disorders 2026

View at publisher
Authors: Katarina Tešija, Mašan Sredanović, Laura Zanetti, Tereza Gabelić, Ivan Adamec, Barbara Barun, Magdalena Krbot Škorić, Mario Habek
DOI: 10.1016/j.msard.2026.107373
Cited by: 1
References: 17

Fields of Study & Subjects

Multiple Sclerosis Research Studies Peripheral Neuropathies and Disorders Rheumatoid Arthritis Research and Therapies

Publication details

Journal / source
Multiple Sclerosis and Related Disorders
Publisher
Elsevier BV
Volume
113
Pages
107373–107373
Publication date
4 July 2026
Language
EN